Women and Lung Cancer Research and Preventive Services Act of 2025
Summary
S.1157 is a procedural bill requiring an interagency review of lung cancer research in women and underserved populations. It authorizes zero funding and creates no direct revenue or cost impact for any publicly traded company. The bill remains on the Senate Legislative Calendar with no scheduled floor vote.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.No funding authorized or appropriated by this bill.
- 2.No regulatory or procurement mandate affecting any public company.
- 3.Action history shows steady committee progress but no floor schedule yet.
- 4.Companion bill HR2319 increases passage probability but does not change the zero-funding reality.
Market Implications
There are no market implications from this legislation. It is a procedural, informational bill that authorizes no spending and creates no requirements for any private sector entity. Healthcare investors should monitor follow-on appropriations bills or subsequent legislation that actually funds lung cancer screening or research initiatives, but S.1157 itself is a non-event for equity markets.
Full Analysis
The Women and Lung Cancer Research and Preventive Services Act of 2025 (S.1157) was placed on the Senate Legislative Calendar on January 28, 2026, after being reported favorably by the HELP committee with an amendment. The bill does not authorize any spending; it directs the HHS Secretary to conduct an interagency review and submit recommendations on accelerating lung cancer research, improving screening access, and launching public awareness campaigns. Because this is a review-and-report mandate—no grants, procurement, tax credits, or regulatory changes—there is zero direct financial impact on any healthcare company. Lung cancer diagnostic firms (e.g., $EXAS, $GH) or biopharma companies developing lung cancer therapies ($MRK, $BMY, $LLY, $RHHBY) would only be affected if the review later leads to specific funding legislation or guideline changes, which is at least one appropriations cycle away. The companion bill HR2319 is identical and has also reached Senate calendar status, indicating modest bipartisan support but no immediate market catalyst. The legislative path forward requires a floor vote and passage in both chambers, followed by presidential action. Given the purely informational nature and absence of any money allocation, the market impact is negligible.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Benay Taub Lung Cancer Research Act
Women and Lung Cancer Research and Preventive Services Act of 2025
Increasing Access to Lung Cancer Screening Act
Lung Cancer Screening Expansion Act of 2025
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →